INTRACAVITARY BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF SUPERFICIAL BLADDER TUMORS

被引：42
|
作者：
Morales, A. [1 ]
Eidinger, D.
Bruce, A. W.
机构：
[1] NIH, Lab Immunodiagnosis, Bldg 8,Room 118, Bethesda, MD 20014 USA
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 02期
关键词：
BCG; CANCER; CARCINOMA; MELANOMA; THERAPY;
D O I：
10.1016/j.juro.2016.10.101
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.
引用
收藏
页码：S142 / S144
页数：3
相关论文
共 50 条
  • [41] Optimal Dose and Duration of bacillus Calmette-Guerin Therapy for Urothelial Carcinoma of the Bladder
    Homma, Yukio
    Nakagawa, Tohru
    JOURNAL OF UROLOGY, 2016, 195 (01) : 9 - 10
  • [42] The natural history of bladder carcinoma in situ after initial response to bacillus Calmette-Guerin immunotherapy
    Gofrit, Ofer N.
    Pode, Dov
    Pizov, Galina
    Zorn, Kevin C.
    Katz, Ran
    Duvdevani, Mordechi
    Shapiro, Amos
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2009, 27 (03) : 258 - 262
  • [43] Reactive arthritis following treatment with intravesical Bacillus Calmette-Guerin for papillary carcinoma of bladder
    Singh, Yogesh Preet
    Roy, Debaditya
    Jois, Bhargavi
    Shetti, Mohit
    BMJ CASE REPORTS, 2022, 15 (04)
  • [44] The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer
    Gontero, Paolo
    Bohle, Andreas
    Malmstrom, Per-Uno
    O'Donnell, Michael A.
    Oderda, Marco
    Sylvester, Richard
    Witjes, Fred
    EUROPEAN UROLOGY, 2010, 57 (03) : 410 - 429
  • [45] A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer
    Gupta, Sachin
    Singh, Balraj
    Bhatt, Harshil
    Singh, Sandeep
    Gupta, Sorab
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [46] Bacillus Calmette-Guerin immunotherapy for genitourinary cancer
    Gandhi, Nilay M.
    Morales, Alvaro
    Lamm, Donald L.
    BJU INTERNATIONAL, 2013, 112 (03) : 288 - 297
  • [47] Disseminated Bacillus Calmette-Guerin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guerin Vaccinations
    Lee, Pamela P. W.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (08) : 297 - 301
  • [48] INTRAVESICAL BACILLUS CALMETTE-GUERIN IMMUNOPROPHYLAXIS OF SUPERFICIAL BLADDER-CANCER - RESULTS OF A CONTROLLED PROSPECTIVE TRIAL WITH MODIFIED TREATMENT SCHEDULE
    MELEKOS, MD
    CHIONIS, H
    PANTAZAKOS, A
    FOKAEFS, E
    PARANYCHIANAKIS, G
    DAUAHER, H
    JOURNAL OF UROLOGY, 1993, 149 (04) : 744 - 748
  • [49] A 12 versus 6-week course of bacillus Calmette-Guerin prophylaxis for the treatment of high risk superficial bladder cancer
    Gruenwald, IE
    Stein, A
    Rashcovitsky, R
    Shifroni, G
    Lurie, A
    JOURNAL OF UROLOGY, 1997, 157 (02) : 487 - 491
  • [50] Loss of Bacillus Calmette-Guerin Viability Adversely Affects the Direct Response of Urothelial Carcinoma Cells to Bacillus Calmette-Guerin Exposure
    Shah, Gopitkumar
    Zhang, Guangjian
    Chen, Fanghong
    Cao, Yanli
    Kalyanaraman, Balaraman
    See, William
    JOURNAL OF UROLOGY, 2014, 191 (03) : 823 - 829
12345